Research May 20, 2026 GLP-1 and Restaurants: Shifting Habits, Not Shrinking Demand Restaurants remain deeply embedded in the lifestyles of GLP-1 users According to a recent consumer survey conducted by the National Restaurant Association, roughly one in eight adults are currently taking some form of GLP-1 medication, and that is expected to rise significantly in the months and years ahead
Typically administered via subcutaneous injections, it provides users with a straightforward and efficient method of delivery
Ongoing and Upcoming Clinical Trials Clinical trials are essential to determine the safety and efficacy of semaglutide for fibroid management
In addition to providing care for patients, the clinic serves as a graduate medical education (GME) facility, training resident physicians
The longer-term BALANCE Model, starting in Medicare Part D in 2027, aims to make this coverage more permanent